drugset / Trial / NCT01812135
Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants
RandomizedParallel-groupDouble-blindPrevention
Summary
A randomized, double-blind, phase II-02 clinical trial is to evaluate the safety and immunogenicity of an inactivated EV71 vaccine with or without aluminum adjuvant
Timeline
- Start
- 2011-09
- Primary completion
- 2011-11
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EV71 vaccine | Vaccine | 400 iu | — |